Tawanda Gumbo - Publications

Rigor and reproducibility of hollow-fiber infection model for antiviral pharmacokinetics/pharmacodynamics studies.

Journal: Antimicrobial agents and chemotherapy

Published: September 03, 2026

Systematic and quantitative analyses of hollow fiber model of Mycobacterium abscessus lung disease studies and new dosing recommendations.

Journal: Microbiology spectrum

Published: April 21, 2026

Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease.

Journal: Antimicrobial agents and chemotherapy

Published: April 09, 2026

Rifamycin-, macrolide-, and ethambutol-free combinations to treat Mycobacterium avium complex lung disease.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 27, 2026

Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.

Journal: Antimicrobial agents and chemotherapy

Published: December 19, 2025

Mycobacteria susceptibility to epetraborole: how far can it go?

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: December 18, 2025